1187652-41-0

Upstream product

• 33539-20-7 6-methoxy-2,5-dihydroxyacetophenone 
• 100-39-0 benzyl bromide 

Downstream Products

• 1187652-42-1 acetic acid 2-acetyl-4-benzyloxy-3-methoxy-phenyl ester 
• 1312761-86-6 C₁₇H₁₄FNO₄ 
• 1312761-85-5 5,6-dihydroxy-2-[(2-methyl-benzylamino)-methyl]-chromen-4-one 
• 1312762-19-8 C₂₅H₂₂N₂O₆ 
• 1312762-18-7 C₂₅H₂₃NO₅ 
• 1312762-17-6 C₂₅H₂₂INO₄ 
• 1312762-16-5 C₂₅H₂₂BrNO₄ 
• 1312762-14-3 C₂₅H₂₂FNO₄ 
• 1312762-13-2 C₂₆H₂₅NO₄ 
• 1312762-12-1 C₂₅H₂₂N₂O₆ 
• 1312762-11-0 C₂₅H₂₃NO₅ 
• 1312762-10-9 C₂₅H₂₂INO₄ 
• 1312762-09-6 C₂₅H₂₂BrNO₄ 
• 1312762-07-4 C₂₅H₂₂FNO₄ 

Relevant academic research and scientific papers

2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity

Anti-HCV activity of aryl diketoacid (ADK) has been characterized by its two pharmacophoric elements, α,β-diketo acid moiety and substituted aryl ring. In this study, as a part of our ongoing efforts to discover a novel anti-HCV compound mimicking the ADK

Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives

Aryl diketoacids have been identified as the first SARS-CoV NTPase/helicase inhibitors with a distinct pharmacophore featuring an arylmethyl group attached to a diketoacid. In order to search for the pharmacophore space around the diketoacid core, three c